Trials / Completed
CompletedNCT02709902
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo, Controlled, Parallel-group Study, Comparing Adapalene/BP Gel, 0.3%/2.5% to EPIDUO® FORTE GEL and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 460 (actual)
- Sponsor
- Sun Pharmaceutical Industries, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Bioequivalence with Clinical Endpoints.
Detailed description
Randomized, Double-Blind, Placebo-Controlled, Multiple-Site, Parallel Design, Bioequivalence with Clinical Endpoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene/BP gel, 0.3%/2.5% | Gel |
| DRUG | EPIDUO® FORTE | Gel |
| DRUG | Placebo | Gel |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-02-01
- Completion
- 2016-03-01
- First posted
- 2016-03-16
- Last updated
- 2017-05-04
Source: ClinicalTrials.gov record NCT02709902. Inclusion in this directory is not an endorsement.